版本:
中国

BRIEF-Aerie Pharmaceuticals reports Q4 GAAP loss per share of $0.87

March 7 Aerie Pharmaceuticals Inc

* Aerie Pharmaceuticals reports fourth quarter and full year 2016 financial results and provides business update

* Q4 adjusted loss per share $0.72

* Q4 earnings per share view $-0.67 -- Thomson Reuters I/B/E/S

* Q4 GAAP loss per share $0.87

* Rhopressa NDA resubmitted, and readouts from rocket 4 and mercury 2 on track for Q2 of 2017 Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐